These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7670225)

  • 61. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of epidemic measles on immunization rates.
    Goldstein KP; Philipson TJ; Joo H; Daum RS
    JAMA; 1996 Jul; 276(1):56-8. PubMed ID: 8667540
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Large measles outbreak at a German public school, 2006.
    Wichmann O; Hellenbrand W; Sagebiel D; Santibanez S; Ahlemeyer G; Vogt G; Siedler A; van Treeck U
    Pediatr Infect Dis J; 2007 Sep; 26(9):782-6. PubMed ID: 17721371
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevention of measles in Israel: short- and long-term intervention strategies.
    Tulchinsky TH
    Isr J Med Sci; 1991 Jan; 27(1):22-9. PubMed ID: 1995496
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lessons from measles vaccination in developing countries.
    Hall AJ; Cutts FT
    BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factors affecting compliance with the measles vaccination schedule in a Brazilian city.
    Logullo P; Barbosa de Carvalho H; Saconi R; Massad E
    Sao Paulo Med J; 2008 May; 126(3):166-71. PubMed ID: 18711656
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Implementing the communication for development strategy to improve knowledge and coverage of measles vaccination in western Chinese immunization programs: a before-and-after evaluation.
    Lu M; Chu YZ; Yu WZ; Scherpbier R; Zhou YQ; Zhu X; Su QR; Duan MJ; Zhang X; Cui FQ; Wang HQ; Zhou YB; Jiang QW
    Infect Dis Poverty; 2017 Apr; 6(1):47. PubMed ID: 28434402
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Measles outbreak in Juneau, Alaska, 1996: implications for future outbreak control strategies.
    Landen MG; Beller M; Funk E; Rolka HR; Middaugh J
    Pediatrics; 1998 Dec; 102(6):E71. PubMed ID: 9832599
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine.
    Vitek CR; Aduddell M; Brinton MJ; Hoffman RE; Redd SC
    Pediatr Infect Dis J; 1999 Jul; 18(7):620-3. PubMed ID: 10440438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Waning of vaccine-induced immunity: is it a problem in Africa?
    Aaby P; Cisse B; Simondon F; Samb B; Soumaré M; Whittle H
    Am J Epidemiol; 1999 Feb; 149(4):304-5. PubMed ID: 10025471
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.
    Leuridan E; Van Damme P
    Vaccine; 2007 Aug; 25(34):6296-304. PubMed ID: 17629601
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules.
    Fowlkes AL; Witte D; Beeler J; Audet SA; Broadhead R; Bellini WJ; Cutts F; Helfand RF
    Vaccine; 2016 Mar; 34(12):1459-64. PubMed ID: 26873052
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules.
    de Francisco A; Hall AJ; Unicomb L; Chakraborty J; Yunus M; Sack RB
    Vaccine; 1998 Apr; 16(6):564-8. PubMed ID: 9569466
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The measles epidemic in Calgary 1969-70; the protective effect of vaccination for the individual and the community.
    O'Neil AE
    Can Med Assoc J; 1971 Oct; 105(8):819-25. PubMed ID: 5170695
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A review of measles supplementary immunization activities and the implications for Pacific Island countries and territories.
    Clements CJ; Soakai TS; Sadr-Azodi N
    Expert Rev Vaccines; 2017 Feb; 16(2):161-174. PubMed ID: 27690704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries.
    Cisse B; Aaby P; Simondon F; Samb B; Soumaré M; Whittle H
    Am J Epidemiol; 1999 Feb; 149(4):295-301. PubMed ID: 10025469
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G; Rasidah N; Wan S; Cutter J
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme.
    Broliden K; Levén B; Arneborn M; Böttiger M
    Scand J Infect Dis; 1998; 30(1):23-7. PubMed ID: 9670354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.